Introduction
The Ternary Complex Factors (TCFs), Elk-1, SAP-1 and NET/SAP-2, are a family of extracellular signalregulated Ets-domain transcription factors. The principal site of TCF activity is the Serum Response Element (SRE), found in many growth factor-inducible promoters, to which they bind as a ternary complex with another transcription factor. Serum Response Factor (SRF; for review see Treisman, 1995) . The C-terminal regulatory region of each TCF contains multiple copies of the MAP kinase core consensus S/T-P, and can be phosphorylated by MAP kinases in vitro; in vivo, growth factor or stress stimulation induces TCF phosphorylation via both the Ras-controlled ERK and the stress-activated SAPK/JNKs and p38 MAPK pathways (Cavigelli et al., 1995; Gille et al., 1995a,b; Janknecht et al., 1993; Janknecht and Hunter, 1997; Marais et al., 1993; Price et al., 1996; Raingeaud et al., 1996; Whitmarsh et al., 1995) . Functional studies have shown that TCF phosphorylation potentiates transcriptional activation and in some assays DNA binding (Gille et al., 1995a; Janknecht et al., 1993; Marais et al., 1993) . At the c-fos promoter, TCF binding to the SRE is essential for regulation of transcription by the Ras-Raf-ERK signalling pathway (Graham and Gilman, 1991; Hill and Treisman, 1995; Kortenjann et al., 1994; Price et al., 1996) .
While the role of phosphorylation in the regulation of TCF activity is well established our knowledge of the sites involved, and the stoichiometry and kinetics of phosphorylation, remains incomplete. Although peptide mapping studies have established that of Elk-1 residues S324, T336, S383, S389 and S422 can be phosphorylated following growth factor stimulation in vivo and by ERK2 in vitro, phosphorylations at the other four S/T-P motifs have not been detected, although these sites are conserved in all the family members (Gille et al., 1995a; Janknecht et al., 1993; Marais et al., 1993; Miranti et al., 1995) . Alanine substitution of Elk-1 residues S383 or S389 substantially reduces its activity in functional assays, but analogous mutations at other sites have little eect unless introduced in combination (Gille et al., 1995a; Janknecht et al., 1993; Kortenjann et al., 1994; Marais et al., 1993) . One possible explanation for this result is that the S383A and S389A mutations, and other mutations at conserved hydrophobic residues in the Elk-1 C-terminal region which signi®cantly impair transcriptional activation (Price et al., 1995) , impair phosphorylation at the other sites. Finally the overall stoichiometry of Elk-1 phosphorylation following growth factor stimulation remains unclear. In this paper we address these issues using antisera speci®c for each of the conserved dierent Elk-1 phosphorylation sites.
T368 and S389. In addition, two more S/T-P motifs at Elk-1 residues 417 and 422 are conserved in either the mouse or human homologues of SAP-1 and SAP-2 ( Figure 1 ). The other Elk-1 S/T-motifs, and S324 and T336, are not conserved in other members of the TCF family, nor are they located in regions of signi®cant primary sequence homology between the three proteins (Price et al., 1995) ; for these reasons we have not further investigated them. Peptides encompassing the conserved C-box sites and residue T417 (which is conserved amongst the entire family apart from mouse SAP-1a), either containing or lacking phosphate at the appropriate sites, were synthesized, coupled to KLH and used to immunize rabbits (see Materials and methods).
We tested whether the antisera recognized phosphorylated Elk-1 using a recombinant Gal4/Elk-1 expressed by a baculovirus vector. In this system, coexpression with oncogenic Ras mutant Ras.V12 and ERK2 allows phosphorylation of the Elk-1 C terminal region during viral infection (Figure 2a , compare lanes 1 and 2). Each of the antisera was used to probe immunoblots prepared from phosphorylated or nonphosphorylated extracts in the presence or absence of 10 mM unphosphorylated peptide. Antisera against peptides phosphorylated at T353, T363, T368, and S383 preferentially reacted with the phosphorylated material, and the majority of this reactivity was resistant to competition with unphosphorylated peptide (Figure 2b ± e, compare lanes 1 and 2 with 3 and 4). The antibodies against phospho-S389 reacted poorly, and was substantially competed with unphosphorylated peptide (Figure 2f ). The antiserum against phospho-T417 was also partially competed by unphosphorylated peptide (Figure 2g ). Increased concentrations of unphosphorylated competing peptide did not diminish the signals further (data not shown). The results obtained using crude antiserum in the presence of competing unphosphorylated peptide were identical to those following depletion of reactivity against unphosphorylated material by chromatography on columns containing unphosphorylated peptide (data not shown; see Materials and methods).
Elk-1 phosphoepitopes are substantially distinct
In addition to the conserved S/T-motifs, the Elk-1 Cterminal phosphorylation sites contain varying amounts of primary sequence identity (see Figure 1) . It was therefore important to evaluate the epitope speci®city of the dierent antisera. For these studies we used the sensitive gel mobility-shift assay to examine extracts of T13 cells, a NIH3T3 derivative which overexpresses Elk-1 some 20-fold. In these assays Elk-1 ternary complexes, formed with the DNA binding domain of SRF and c-fos SRE probe, are resolved by native gel electrophoresis. Phosphorylation of the Cterminal domain following serum stimulation induced a transient reduction in the mobility of the ternary complex (Marais et al., 1993; Figure 3, band TC, top left) . Each of the antibodies supershifted the Elk-1 ternary complex in the presence of non-phosphorylated peptide, but only in extracts of serum-stimulated cells (Figure 3, supershift) . Interestingly, the anti-S383-P and anti-S389-P antisera both caused substantially greater retardation of the ternary complex than the other antisera (see Discussion). In double antibody supershift experiments, phosphorylation of S383, T368, T417 could be detected simultaneously (data not shown). However, none of the antisera quantitatively supershifted the ternary complex under a variety of experimental conditions, even when concentrated antibody preparations were used; in a control experiment, concentrated anti-S383-P serum was also unable to supershift recombinant Elk-1 phosphorylated by ERK2 to saturation (estimated stoichiometry of 12 mol phosphate per mol protein; data not shown). We therefore believe that the partial supershifts we observe re¯ect poor avidity of the antibodies for their cognate sites rather than partial phosphorylation of the protein.
To evaluate cross-reactivity of the dierent antisera we tested whether the supershifts were sensitive to Figure 1 TCF C-termini, phosphopeptides, and S/T-P motifs. Elk-1, SAP-1 and SAP-2 C-terminal sequences, including the`Cbox' (Dalton and Treisman, 1992) are shown, with S/T-P motifs reverse-shaded. Identity is indicated by vertical lines, similarity by colons: note that in mouse SAP-1 the`417' T-P is not conserved, while in mouse Net (SAP-2) the`422' S-P is present (Giovane et al., 1994) . Peptides used for immunization are overlined, with phosphorylations indicated by open circles. The SAP-1 peptide used for competition studies is also shown. The sequences surrounding each of the C-terminal S/T-P motifs are aligned at the bottom Figure 2 Antisera react preferentially with phosphorylated Elk-1. Extracts of infected Sf9 cells expressing either Gal4(1-94)-ElkC alone (odd lanes) or coexpressed with RasV12 and ERK2 (even lanes) were fractionated by SDS ± PAGE, immunoblotted and probed with the indicated antisera, either alone or in the presence of 10 mM unphosphorylated cognate peptide (`un-P peptide'). Anti C-ter is an antiserum directed against the unphosphorylated Elk-1 C-terminal peptide (Marais et al., 1993) Figure 3 Elk-1 phospho-epitopes show little cross-reactivity. Gel mobility-shift reactions were set up containing extract (7.5 mg) from serum-starved and serum-stimulated cells as indicated together with SRF(133-265) protein and c-fos SRE probe. Reactions were incubated with antisera as indicated on the ®gure, together with the indicated peptides at 10 mM; peptides showing signi®cant cross reactivity are highlighted by asterisks. All reactions containing phosphopeptide competitors also included the unphosphorylated peptide, apart from those with the anti S383-P serum, for which anity puri®ed antibody was used inclusion of excess phosphopeptide other than the cognate. At 10 mM competing phosphopeptide, very little cross-reactivity was detectable, apart from competition of the T368 and S389 phosphopeptides with the T353 and S383 epitopes respectively (Figure 3 , asterisks). The SAP-1 S381-P peptide failed to crossreact with the highly homologous Elk-1 S383-P epitope (Figure 3, lower left) . At high competing phosphopeptide concentrations, however, greater cross reactivity was observed with several peptides (data not shown). These data show that the dierent phosphorylated epitopes are substantially distinct, suggesting that it is likely that each antiserum is substantially speci®c for its cognate phosphopeptide, and that serum stimulation induces phosphorylation of Elk-1 at each of the dierent sites.
Each antiserum is sequence-specific
To test the speci®city of the antisera more rigorously we examined Elk-1 point mutants in which each phosphoacceptor residue is individually mutated to alanine (Gille et al., 1995a; Marais et al., 1993) . NIH3T3 cells were transiently transfected with expression plasmids encoding each mutant, stimulated with serum or phorbol ester to activate the ERK pathway, and extracts analysed using the supershift assay. For each antibody, supershifting of the activated ternary complex was abolished when its cognate site was mutated to alanine ( Figure 4a ; compare lanes 2 with 5, 3 with 6). To exclude the possibility that each mutation induces a change in the structure of the C-terminal region that precludes reactivity with any of the antibodies, we examined the reactivity of each mutant with each of the other antisera using immunoblot assays. Unfortunately the antisera could only be used for immunoblotting in assays using transiently overexpressed protein, and the anti T353-P antiserum did not give reproducible results even in this assay. In these assays, reactivity of the wildtype protein with each antiserum was again detectable only upon serum stimulation, and was abolished by mutation of the cognate phosphoacceptor site to alanine ( Figure 4b , lanes 1 ± 4). Reactivity was not abolished by mutation of phosphoacceptor sites other than the cognate ( Figure 4b , lanes 5 ± 9). These data show that under these conditions each antiserum is speci®c for its cognate site, and demonstrate that in no case is phosphorylation of one site a prerequisite for phosphorylation of another.
Hydrophobic core mutations do not affect Elk-1 phosphorylation
We previously showed that three mutations in a conserved hydrophobic sequence abolishes regulated transcriptional activation by the Elk-1 C-terminal region (mutants F378A, W379A and DFW; Price et al., 1995) . To test whether these mutations aect ternary complex formation or phosphorylation of Elk-1 following serum stimulation, we transferred them into the full length protein and expressed them by transient transfection in NIH3T3 cells. Following serum stimulation, extracts were prepared and ternary complexes were examined by gel mobility-shift assay. All three mutants formed ternary complexes indistinguishable from those formed by the wildtype protein, which underwent further reduction in mobility upon serum stimulation ( Figure 5 , compare lanes 1 and 2). Each of the antisera supershifted the mutant complexes similarly to complexes formed by wildtype Elk-1 ( Figure 5 , compare lanes 3 ± 8). The eects of these mutations on transcriptional activation therefore do not arise from defective phosphorylation.
Kinetics of phosphorylation of Elk-1
A number of studies in NIH3T3 and HeLa cells have demonstrated that TCF modi®cation, as assessed by generation of retarded ternary complexes in the gel mobility shift assay, correlates with the kinetics of MAP kinase activation (Hipskind et al., 1994; Marais et al., 1993; Zinck et al., 1993) . Such studies do not allow the kinetics of phosphorylation at individual sites to be inferred, however, since phosphoacceptor point mutants undergo similar mobility changes to the wildtype protein upon stimulation (Marais et al., 1993) . Unfortunately, the sensitivity of the antibodies did not allow us to address the modi®cation of endogenous Elk-1 following stimulation of susceptible cell lines, so we again utilized the Elk-1 overexpressing T13 cell line. Extracts were prepared at various times after stimulation with serum or TPA and analysed by gel mobility-shift assay using the various antisera. Similar kinetics of phosphorylation were observed at each of the S/T-P motifs tested. Phosphorylation was detectable within 2 min following stimulation, reached a peak between 5 and 15 min and began to decline between 15 and 30 min following stimulation. After 60 min Elk-1 was substantially dephosphorylated, as assessed both by reduced immunoreactivity and by the restoration of the fast-moving form of the ternary complex. Similar kinetics of phosphorylation were observed with each antibody (Figure 6a compare lanes 1 ± 7), and upon stimulation with TPA (data not shown). The kinetics of phosphorylation of Elk-1 were similar to those with which active ERK2 accumulated in the nucleus, as assessed by immuno¯uorescence using an activation-speci®c ERK2 antibody (data not shown).
We used a similar approach to track the phosphorylation kinetics of the Elk-1 mutant S383A. This mutation, and the S389A mutation, is sucient to signi®cantly impair transcriptional activation by both Elk-1 and by Gal4 or LexA fusion proteins, unlike the analogous mutations at the other sites (Gille et al., 1995a; Janknecht et al., 1993; Marais et al., 1993) . Extracts were prepared from the NIH3T3 derivative T18 cells, which express Elk-1 S383A at levels similar to those of wildtype Elk-1 in T13 cells. Modi®cation of the S383A mutant proceeded to a similar extent and with essentially identical kinetics to that of the wildtype protein, apart from the lack of S383 phosphorylation, and an apparently more prolonged phosphorylation of S389 (Figure 6b ). The deleterious eects of the single S383A mutation on transcriptional activation must therefore re¯ect its eects on the function of the Elk-1 C-terminal domain rather than alterations its phosphorylation (see Discussion).
Stoichiometry of Elk-1 phosphorylation
As described in the preceding sections none of the antisera was capable of quantitatively supershifting the Elk-1 ternary complex in gel mobility-shift experiments. Similar results were obtained in control experiments using recombinant Elk-1 phosphorylated in vitro to high stoichiometry; it is therefore likely that the failure to obtain complete supershift of the ternary complex re¯ects the poor avidity of the antisera, rather than incomplete phosphorylation of the Elk-1 in cell extracts. To address the stoichiometry of Elk-1 phosphorylation in vivo we therefore turned to twodimensional gel electrophoresis analysis of Elk-1 immunoprecipitates. To maximize recovery of Elk-1 protein in these experiments we used F13 cells, an NIH3T3 cell derivative which overexpresses Flag epitope-tagged Elk-1 at similar levels to T13 cells. Extracts from serum-starved and TPA-stimulated cells were immunoprecipitated with anti Flag antibodies and subjected to 2D gel analysis. Elk-1 was detected by immunoblotting with Flag antibody; signals from contaminating Ig on the blots allowed the dierent gels to be compared. In serum-starved cells the majority of Elk-1 protein was present as a doublet with pI approximately 6.5; these species did not detectably react with a concentrated preparation of anti-S383-P antibody, suggesting that they may correspond to basal phosphorylations seen in the Nterminal part of the protein (Marais et al., 1993 ; Figure  7a , panel 1, spots A,B; data not shown). Upon TPA stimulation, this major Elk-1 doublet was rapidly converted into more acidic forms, a total of at least eight additional forms being detectable 5 min following stimulation ( Figure 7a, panel 2) . Strikingly there was an abrupt discontinuity in the spacing of the dierent forms, which could not be altered by changing the IEF conditions (data not shown). This discontinuity was 1 and 4) , serum-stimulated (lanes 2 and 5) or TPA-stimulated (lanes 3 and 6) transfected cells were prepared and used in gel mobility-shift reactions with SRF(133-265) and c-fos SRE probe. Reactions contained 2.5 ml of the indicated antisera together with 10 mM nonphosphorylated cognate peptide; supershifts are indicated by asterisks. (b) Immunoblot analysis. NIH3T3 cells were transfected with wildtype or point mutant Elk-1 expression plasmids and maintained in 0.5% serum for 24 h before stimulation with 15% serum for 15 min. Total cell lysates from starved (lanes`7') and stimulated (lanes`+') cells expressing the indicated mutants were prepared and analysed by immunoblotting with the dierent antisera as indicated not observed upon phosphorylation of a fusion protein containing the C-terminus of Elk-1 joined to GST, which generates species evenly spaced across the pH gradient (data not shown; see Discussion). By 15 min following stimulation virtually all detectable Elk-1 was in the three most acid forms, while after 30 min lower acidity forms were again detectable (Figure 7a panels 3  and 4) . Analysis of transiently expressed Flag-tagged Elk-1, which gave similar results, showed that many fewer spots were detectable when mutation of residues T363, T368, S383 and S389 are simultaneously substituted by alanine, indicating that these changes are dependent on the presence of the C-terminal MAPK sites (data not shown).
The above results show that Elk-1 accumulates multiple modi®cations following TPA stimulation, but do not allow an easy assessment of stoichiometry owing to the heterogeneity of Elk-1 isoforms in serum- Figure 5 Mutations at conserved hydrophobic residues do not prevent phosphorylation of Elk-1 S/T-P motifs. NIH3T3 cells were transfected with expression plasmids encoding either wildtype Elk-1 (a) or mutants DFW (b), W379A (c) or F378A (d). Extracts were prepared from serum-starved (lane 1), or serum-stimulated (lanes 2 ± 8) cells and used in gel mobility-shift reactions with SRF(133-265) and c-fos SRE probe. Reactions contained 2.5 ml of the following antisera together with 10 mM nonphosphorylated peptide as follows: Lanes 1 and 2, no antibody; lane 3, anti T353-P; lane 4, anti T363-P; lane 5, anti T368-P; lane 6, anti S383-P; lane 7, anti S389-P; lane 8, anti T417-P Figure 6 Kinetics of phosphorylation at C-terminal phosphoacceptor sites. Stably transfected NIH3T3 cell lines expressing either wildtype Elk-1 (a) or the Elk-1 S383A mutant (b) were serum-starved and then restimulated for the times indicated on the ®gure. Extracts were prepared and used in gel mobility-shift reactions with SRF(133-265) and c-fos SRE probe in the presence of contained 2.5 ml of each antiserum together with 10 mM nonphosphorylated peptide Phosphorylation of Ternary Complex Factor Elk-1 FH Cruzalegui et al starved cells. In principle, addition of a single phosphate to the C-terminal region of spot B could cause it either to shift such that it comigrates in IEF with spot A, or to`leapfrog' spot A and comigrate with the spot to its right. To address this issue we sought to ®rst remove any basal phosphorylations from Elk-1 and then to test the eects of partial rephosphorylation by ERK2. Alkaline phosphatase treatment was used to test whether the multiple Elk-1 species in serum-starved cells arise from basal levels of phosphorylation of the protein. Phosphatase-treated Elk-1 migrated with a mobility apparently similar to that of a minor spot visible in untreated samples (Figure 7b , panels 1 and 2, spot C; data not shown). The phosphatase-treated material was then rephosphorylated to dierent extents using activated recombinant ERK2. Limiting rephosphorylation in vitro by ERK2 generated Elk-1 isoforms with IEF properties similar to those seen in serumstarved cells, while more extensive phosphorylation led to accumulation of a cluster of spots similar to that seen upon peak phosphorylation of Elk-1 following TPA stimulation in vivo (Figure 7b , compare panels 3 and 4).
A simple interpretation of the 2D gel pattern of Elk-1 following the 5 min TPA stimulation is given in Figure 7c . This interpretation assumes that a single phosphorylation at any one site in the C-terminal region induces a similar change in pI, as suggested by the experiments with GST-ElkC described above. A reasonable interpretation of the dephosphorylationrephosphorylation data is that each of the dierent spots seen in vivo represents addition of a single phosphate group to the Elk-1 C-terminal region. We suggest that the two dierent starting Elk-1 species, A and B, themselves dier by one phosphate, and each receive up to seven phosphorylations by 5 min following stimulation. We propose that the large discontinuity in spacing of the dierent species arises because the addition of a fourth phosphate group results in a disproportionate increase in acidity, perhaps re¯ecting induction of a conformational change in the protein (see Discussion). The data are consistent with a model in which Elk-1 molecule has acquired at least six phosphates by the peak time of phosphorylation; it is thus likely that the majority of the Elk-1 C-terminal regulatory sites become phosphorylated upon activation of the ERK pathway in vivo.
Discussion
We have investigated phosphorylation of the Elk-1 transcription factor using antisera directed against the phosphorylated forms of S/T-P MAPK consensus motifs present in its C-terminal regulatory region. Our data provide direct evidence for phosphorylation of residues T353, T363, T368, S383, S389 and T417, which are conserved between members of the Ternary Complex Factor family. All these sites exhibit similar kinetics of modi®cation following serum or TPA stimulation, and phosphorylation appears to occur independently at individual sites. Previous studies have demonstrated phosphorylation of Elk-1 residues S383, S389 and S422, and two other S/T-P motifs at residues S324 and T336 which are speci®c to Elk-1 (Gille et al., 1995a; Janknecht et al., 1993; Marais et al., 1993; Miranti et al., 1995) . We used two dimensional gel electrophoresis to investigate the stoichiometry of phosphorylation of the Elk-1 C-terminal region following ERK activation in vivo. Interpretation of these data was complicated by the presence of multiple phosphorylated forms of the protein in serum-starved cells, but the data are consistent with a model in which during TPA stimulation of NIH3T3 cells, each Elk-1 molecule receives at least six phosphate groups in its Cterminal region at the time of maximum phosphorylation. Ecient phosphorylation of the Elk-1 regulatory domain is probably achieved by direct recruitment of ERKs through their interaction with sequences upstream of the conserved C-terminal domain (Yang et al., 1997) . It will be interesting to use the antibodies to investigate phosphorylation of the Elk-1 C terminus by dierent MAP kinases, since previous studies have shown that the SAPK/JNKs and p38 kinases may have subtly dierent speci®city from the ERKs in vitro (Cavigelli et al., 1995; Gille et al., 1995b; Price et al., 1996; Raingeaud et al., 1996; Whitmarsh et al., 1995; Zinck et al., 1995) .
Although our data show that substantially increased phosphorylation occurs following stimulation, data obtained with phosphorylation speci®c antibodies must be interpreted with caution. First, it may well be that phosphoepitopes are ineciently exposed when the protein is only partially phosphorylated, which would lead to an underestimation of the extent of phosphorylation in serum-starved cells. At present, we therefore cannot exclude the possibility that the resting phosphorylations seen in the two-dimensional analysis arise from low-level phosphorylation of the C-terminal region which is ineciently detected by our antisera in the mobility-shift and immunoblot analysis. Second, although our studies show that each antiserum is speci®c for Elk-1 phosphorylated at its cognate site, they do not prove that the phosphate group actually forms part of the epitope. For example, unlike the other sera, the anti-S389-P serum was quantitatively retained on an anity column of immobilized unphosphorylated peptide, even though it reacted speci®cally with phosphorylated material in gel mobility-shift and immunoblot assays in the presence of excess unphosphorylated free peptide. Similar observations have been reported with an antiserum speci®c for the phosphorylated form of SRF serine 103 (Rivera et al., 1993) . The anti S389-P serum might therefore recognize a phosphorylation-dependent conformational epitope that can be also induced in the unphosphorylated peptide upon crosslinking to a solid support. Finally, the S383-P and S389-P antisera caused a substantially greater reduction in mobility of the ternary complex than the other antisera. The reason for this is unclear: perhaps it re¯ects rotational constraint of these epitopes relative to the others.
Our data provide direct evidence that the deleterious eects in functional assays of alanine substitutions at S/T-P motifs arises from failure to phosphorylate these sites. Consistent with this, substitutions of phosphoacceptor residues by acidic residues rather than alanine does not impair function, although such mutants still require MAPK activation to function (Janknecht et al., 1993 (Janknecht et al., , 1995 Kortenjann et al., 1994) . Alanine mutations at the conserved S/T-P motifs have eects of variable severity: while mutation of residue 383 virtually inactivates the protein and mutation of residue 389 substantially impairs function, alanine substitutions at the other sites have little eect unless introduced in combination (Gille et al., 1995a; Janknecht et al., 1993; Kortenjann et al., 1994; Marais et al., 1993) . Our ®nding that the S383A mutation does not aect the kinetics of phosphorylation at other sites rules out a model in which the severity of the S383A mutation arises because phosphorylation at this site is required for ecient phosphorylation of the other sites during the limited period of ERK activity following serum stimulation. An alternative view is that S383 is the predominant site of phosphorylation and that it cooperates functionally with modi®cations at a subset of other residues (Gille et al., 1995a,b) ; however, our ®nding that the majority of the conserved motifs are phosphorylated, and that the overall stoichiometry of phosphorylation is high does not support this view. We favour the idea that the phosphorylated S383 and S389 residues are either involved in interactions with the transcriptional machinery or directly required for generation of the conformation of the Elk-1 regulatory domain.
The TCF regulatory domains exhibit substantial sequence conservation in addition to the conserved phosphorylation sites (Figure 1 ). We previously demonstrated that mutation of conserved hydrophobic residues F378 and W379 abolishes transcriptional activation by LexA-Elk-1 fusion proteins. Introduction of these mutations into full-length Elk-1 neither impairs ternary complex formation with SRF nor aects phosphorylation at any of the conserved S/T-P motifs tested. Thus, increased transcriptional activation by Elk-1 cannot merely re¯ect simple addition of phosphate groups and consequent increased negative charge in the C-terminal region. It is therefore likely that residues F378 and W379 are involved in either maintenance of structural elements of the Elk-1 C terminus, or its interactions with the transcription machinery.
Studies with other transcriptional activation domains such as those of HSV VP16 have suggested that they are unstructured in solution but become structurally constrained upon interaction with components of the basal machinery (O'Hare and Williams, 1992; Shen et al., 1996; Uesugi et al., 1997;  for review see Triezenberg, 1995 ). An attractive model to explain the role of multiple phosphorylations in Elk-1 regulation is that they act to stabilize an active conformation of the C-terminal region, thereby increasing its anity of interaction with the transcriptional apparatus. Indeed, the behaviour of Elk-1 in IEF gels is consistent with the idea that a structural transition in the protein aecting the C-terminal region occurs upon addition of more than four phosphates to it. This transition is not seen with a GST fusion protein containing the C-terminal domain, which suggests that it arises from interactions between the N-and C-terminal regions of the protein, as proposed by Sharrocks (Yang et al., 1999) . Phosphorylated residues within the conserved Cbox region might directly participate in formation of the active structure, while non-conserved S/T-P motifs such as Elk-1 residues S324 and T336 might act nonspeci®cally to destabilize the inactive conformation of the domain. The dramatic eects of the S383A and S389A mutations might re¯ect direct interactions between the phosphorylated residues and coactivators such as CBP/p300 (Janknecht and Nordheim, 1996) or mediator components such as hSur2/CRSP130 (Boyer et al., 1999) ; such phosphorylation-dependent interactions are seen in the interaction between CREB S133-P and CBP (Ishwar-Radhakrishnan et al., 1997) . The identi®cation of Elk-1 targets in the basal transcriptional machinery, and the direct characterization of phosphorylation-induced structural changes in the Elk-1 activation domain, will enable these issues to be addressed.
Materials and methods

Plasmids, proteins and cells
Elk-1 expression plasmids were derivatives of MLV-Elk-1 containing the 9E10 or FLAG epitope tags at the Elk-1 N terminus and previously described point mutations (Gille et al., 1995a; Marais et al., 1993; Price et al., 1995) . Stable NIH3T3 cell lines expressing Elk-1 derivatives were generated by standard procedures using pTKNeo as selectable marker; Elk-1 expression was assessed by immunoblot and ternary complex assays. A baculovirus expressing the Gal4(1-94)-Elk1(307-428) fusion protein was constructed by standard techniques. Sf9 cells were infected with Gal4(1-94)-Elk1(307-428) at 21 pfu/cell, with or without viruses encoding ERK2 (6.2 pfu/cell) and RasV12 (2.4 pfu/cell; gifts from Pablo Rodriguez-Viciana). Transfection was by DEAE-dextran or Lipofectamine methods with serum starvation and stimulation as previously described (Marais et al., 1992 (Marais et al., , 1993 . Sf9 and NIH3T3 cell extracts were prepared and used in gel mobility-shift assays as previously described (Marais et al., 1992 (Marais et al., , 1993 . DNA binding reactions were allowed to proceed for 30 min at room temperature before addition of competitor peptide or up to 2.5 ml antiserum and further incubation for 1 h.
Immunoprecipitation, dephosphorylation and rephosphorylation
Extracts prepared from a 9 cm dish of cells (200 ml) were added to 600 ml D0.0 (20 mM HEPES pH 8.00, 5 mM EDTA, 10 mM EGTA, 5 mM NaF, 50% glycerol, 0.1 mM vanadate, 100 ng/ml okadaic acid containing leupeptin, pesptatin, PMSF and aprotinin and 20 ml pellet anti-FLAG beads (Sigma), and incubated 12 h with agitation 48C. Beads were recovered and washed twice with DO.2 (as D0.0 with 0.2 M KCl, 0.2% TX-100) and twice with D0.0. For 2-D gel analysis, proteins were recovered by addition of 40 ml CHES buer (50 mM CHES, 2% SDS, 10% glycerol, 2% 2-mercaptoethanol).
For phosphatase experiments, the beads were ®rst washed twice in D0.2 without inhibitors, then twice with phosphatase buer (20 mM Tris pH 8.8, 10 mM MgCl 2 , 0.1 mM ZnCl 2 , 0.1% NP-40). Fifty ml of phosphatase buer and 40 units of Alkaline Phosphatase (Boehringer) were added and the beads incubated at 378C with agitation for 1 h before addition of 5 ml stop mix (100 mM KH 2 PO 4 , 100 mM EDTA, 50 mM NaF, 1 mM vanadate and 1 mg/ml okadaic acid).
For kinase reactions beads were ®rst washed twice in kinase buer (20 mM HEPES 7.5, 10 mM Mg(CH 3 COO) 2 , 1 mM EGTA, 1 mM DTT, 100 mM ATP, 5 mM NaF, 100 ng/ ml okadaic acid and 0.1 mM vanadate) and were resuspended in 50 ml kinase buer. Activated ERK2, prepared as described (4 mg/ml stock; Khokhlatchev et al., 1997) , was added as speci®ed in the Figure Legends and incubated on ice for 5 min, following which the beads were recovered, washed twice in 200 ml DO.0, and resuspended in 50 ml CHES sample buer.
Antibodies
Phosphorylated peptides were synthesized as follows using standard techniques, with or without phosphate at the underlined positions: T353; GPALTPSLLPTHT; T363, THTLTPVLLTPSS; T368, PVLLTPSSLPPS; S383, STLSPIAPRSPAK; S389, STLSPIAPRSPAK; T417, SVDGLSTPVVLSPGPQK. Peptide (8 ± 10 mg) and KLH (10 mg; Calbiochem 374817) were dissolved in 5 ml of 0.1 M NaHCO 3 pH 9.6 and crosslinked using gluteraldehyde (0.05% v/v) with stirring at room temperature overnight before addition of glycine ethyl ester to 0.1 M. Proteins were recovered by acetone precipitation and redissolved at 2 mg/ ml in saline. For immunizations 0.2 mg of KLH conjugate was diluted to 1 ml, precipitated by addition of potassium aluminium sulphate to 1%, and neutralized with 2 M KOH; following centrifugation the precipitate was resuspended in 1 ml saline for injections. Two rabbits were immunized per peptide, and at least one showed a response in each case.
The anti S383-P, anti T368-P and anti T417-P antisera could be eciently depleted of reactivity against the unphosphorylated peptide by passage twice through columns containing immobilized unphosphorylated peptide (1 ± 2 ml, 300 mg peptide/g of CNBr-activated sepharose). The anti T353-P antiserum irreparably lost activity in this procedure, however. The anti-S389 antiserum quantitatively bound the column from which phosphospeci®c antibody could be recovered (see Discussion). In most experiments antisera were concentrated by ammonium sulphate precipitation, redissolved in TBS containing 0.1% NP ± 40, 0.1% sodium azide, and routinely used in the presence of 10 mM competing unphosphorylated peptide. For some experiments anti-S383 antibody was anity puri®ed by chromatography on columns containing the S383-P phosphopeptide by 100 mM sodium citrate pH 2.5. For immunoblotting, a crude ammonium sulphate fraction of the antisera was used at 1 : 1000 in the presence of 10 mM nonphosphorylated peptide. Anti-FLAG antibody (Sigma) was used at 1 : 2500, with HRP-conjugated anti-mouse or anti-rabbit immunoglobulin (DAKO; 1 : 5000) as secondary antibody.
Two dimensional gel electrophoresis
For the ®rst dimension, proteins were ®rst separated by IEF as described except that a dierent mix of ampholytes was used. Ampholytes (Pharmacia) were 0.8 ml pH 5 ± 7, 0.4 ml pH 3 ± 5 and 0.24 ml pH 3 ± 10 per 20 ml gel mix. Prefocusing was done as speci®ed (Bravo and Celis, 1984) with focussing at 400 V for 18 h followed by 800 V for 1 h. Following processing IEF gels were stored at 7708C. Second dimension SDS ± PAGE and immunoblotting were by standard methods. The pH gradients were checked using IEF markers (BioRad).
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